antimicrobials Flashcards
(24 cards)
list several sources of antimicrobials
- semi-synthetic:based on an existing natural antibiotic(b-lactanms:ampicillin,aminoglycosides)
- synthetic:relatively rare(sulfa drugs, quinolones, oxazolidinones)
- natural source:from microbes.eg:actinomycetes, fungi
list the major classes of antibiotics with examples
b-lactams.glycopeptides,polypeptides.polymyxins. tetracyclines.aminoglycosides.sulfonamides. isoniazid
describe the different mechanisms of action of major antibiotic classes
- cell wall synthesis:b-lactams,glycopeptides.polypeptides
- nucleic acid synthesis:DNA:quinolones;RNA:rifamycins
- cell membrane disruption:polymyxins
- protein synthesis:bind to 30s&50s
- metabolic antagonism:sulfonamides(sulfa drugs),isoniazid
describe several major mechanisms of drug resistance
- decreased permeablitiy(reduced influx)
- inactivating enzymes
- altered target sites
- active efflux
- alternate pathway
nucleic acid synthesis antibiotic DNA
quinolones:ciprofloxacin, norfloxacin
nucleic acid synthesis antibiotic RNA
rifamycins
nucleic acid synthesis antibiotic RNA
rifamycins
glycopeptides mechanisms
cell wall synthesis:bind to peptidoglycan,blocking transpeptidase action
eg:vancomycin,teicoplanin
polypetides
interferes with bacoprenol, a carrier molecule that moves peptidoglycan precursors across inner cell membrane.
eg.bacitracin
Tetracyclines mechanisms
bind to the 30s ribosomal subunit bacteriostatic activity(G+/-)
Aminoglycosides mechanisms
bind to 30s ribosomal subunit bactericidal activity(G-
streptogramins mechanisms
bind to 50s ribosomal subunit
interfere with folic acid synthesis
sulfonamides
mycobacterial infections
isoniazid
inhibit synthesis of mycolic acid”cord factor”
isoniazid
drug resistance
- decreased permeability(reduce influx)
- inactivating enzymes
- altered target sites
- active efflux
- alternate pathways
alter target sites
target enzyme or organelle is modified eg. modified cell wall intermediates ribosomal point mutation altered penicilin binding proteins low enzyme affinity for the drug mutation in RNA polymerase
vancomycin resistance
modified cell wall intermediates
macrolide resistance
ribosomal point mutation
pencillin resistance
altered penicillin binding proteins
sulfonamide resistance
low enzyme affinity for the drug
rifampin(mycobacterial) resistance
mutation in RNA polymerase
active efflux
drug is physically pumped out of the cell
alternative pathways
use alternative pathway bypasses the sequence inhibited by the agent
OR increase production of the target metabolite
OR pathogen uses preformed folic acid from the surroundings
OR increases the rate of production(overproduction of PABA, increased produciton of enzymes)